Navigation Links
WAVi Co. Announces Collaborative Agreement with SomaLogic, Inc.

BOULDER, Colo., Aug. 1, 2011 /PRNewswire-iReach/ -- WAVi Co. announced today it has entered into a collaboration agreement with SomaLogic, Inc. Under the agreement, WAVi will apply its unique bioinformatics expertise to SomaLogic's proprietary proteomic assays for an undisclosed fee. In addition, the companies agree to work together to plan two clinical research studies in dementia that will combine WAVi's EEG (electroencephalogram)-based biomarkers and SomaLogic's blood-based protein biomarkers.

"This collaboration with SomaLogic validates both our world-class bioinformatics capabilities as well as the potential of WAVi's brain assessment platform – a platform designed as a point of care, rapid screening device providing an objective and accurate measurement to aid in the early detection and diagnosis of cognitive ailments and other neurological disorders," said Stephen K. Onody, President and CEO of WAVi. "Our mission is pre-symptomatic detection leading to early diagnosis enabling timely treatmentof cognitive ailments. Dementia costs the U.S. $183 billion per year and it is estimated that 1 in 8 people will develop Alzheimer's.  The WAVi system is designed to assist physicians to ensure patients are treated or referred to specialist care when need exists."

Larry Gold, PhD, SomaLogic Chief Executive Officer added "We are delighted to begin this collaboration with WAVi, and believe that our unique contributions to our joint work will speed the early detection and diagnosis not just of dementia but many different human diseases, offering the possibility for earlier and more effective therapeutic interventions."

About WAVi Co.

WAVi Co. ( is a privately held, medical technology company developing the first simple to use, low-cost, EEG brain assessment platform suitable for mass screening.  The WAVi device is designed to determine deviation from norm utilizing a normative database and/or self-comparison to aid in early detection and diagnosis of cognitive ailments and other neurological disorders.


About SomaLogic

SomaLogic, Inc., is a privately held biomarker discovery and clinical proteomics company based in Boulder, Colorado. The company's mission is to use its proprietary Slow-Offrate Modified Aptamer ("SOMAmer") technology to develop enhanced protein analysis tools and reagents for the life sciences community, to facilitate target validation, and to develop and commercialize clinical diagnostic products that will improve the delivery of healthcare by offering timely and accurate diagnostic information to physicians and their patients. Further information about SomaLogic can be found at

Media Contact: Stephen Onody WAVi Co., 720-542-3855,

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Vermillion Announces Notice of Allowance for Peripheral Artery Disease (PAD) Patent
2. International Isotopes Inc. Announces Successful International Standards Certification for Manufacture of Its Nuclear Medicine Products and Devices
3. Biocept, Inc. Announces Availability of Its New Breast Cancer Test, OncoCEE-BR™ Utilizing Circulating Tumor Cells (CTCs)
4. TriLink BioTechnologies, Inc. Announces License Agreement with Lucigen Corporation
5. Verenium Announces Debt Repurchase
6. Life Technologies Announces Second Quarter 2011 Results
7. Keryx Biopharmaceuticals Announces Completion of Patient Enrollment in KRX-0401 (Perifosine) Phase 3 Refractory Advanced Colorectal Cancer Study
8. Dyadic International Announces Date of Second Quarter 2011 Financial Results Release and Conference Call
9. MiMedx Group Announces Second Quarter 2011 Results
10. BioDelivery Sciences Announces Completion of BEMA Buprenorphine Phase 3 Chronic Pain Study
11. ADVENTRX Announces Appointment of Senior Vice President, Commercial
Post Your Comments:
(Date:6/23/2016)... -- Houston Methodist Willowbrook Hospital has signed a ... serve as their official health care provider. As ... provide sponsorship support, athletic training services, and most ... athletes and families. "We are excited ... to bring Houston Methodist quality services and programs ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... 2016  Blueprint Bio, a company dedicated to identifying, ... community, has closed its Series A funding round, according ... "We have received a commitment from Forentis Fund ... to meet our current goals," stated Matthew Nunez ... to complete validation on the current projects in our ...
Breaking Biology Technology:
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):